Market Tracker

09/18 7:27am ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

7.41
Data as of Sep 17
 0.00 / 0.00%
Today’s Change
5.40
Today|||52-Week Range
11.88
+0.27%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close7.41
Today’s open7.43
Day’s range-- - --
Volume45,024
Average volume (3 months)66,186
Market cap$321.5M
Dividend yield--
Data as of 09/17/2014

Growth & Valuation

Earnings growth (last year)+76.89%
Earnings growth (this year)-106.46%
Earnings growth (next 5 years)--
Revenue growth (last year)+54.09%
P/E ratioNM
Price/Sales14.53
Price/Book3.31

Competitors

 Today’s
change
Today’s
% change
XNPTXenoport Inc+0.09+1.71%
ACRXAcelRx Pharmaceutica...+0.04+0.55%
ECYTEndocyte Inc+0.24+3.03%
SGYPSynergy Pharmaceutic...0.000.00%
Data as of 09/17/2014

Financials

Next reporting dateNovember 12, 2014
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$19.6M
Annual profit (last year)-$18.7M
Net profit margin-95.40%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, CFO, Director &
CAO
Kleanthis G. Xanthopoulos
Chief Scientific Officer
Neil W. Gibson
Corporate headquarters
San Diego, California

Forecasts